Bayer announced today that the U.S. Food and Drug Administration (FDA) accepted its supplemental New Drug Application (sNDA) and granted Priority Review designation for KERENDIA ® (finerenone), which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results